NervGen Pharma Corp. (NGEN) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts NGEN Hot Sheet
Join SI Premium – FREE
NervGen Pharma Corp. (NASDAQ: NGEN) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on NervGen Pharma Corp. (NGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Silver Lake In Talks To Buy Workday, Sources Say - Reuters
- Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c
- NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
